These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 10976015)

  • 1. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
    Jansen PL
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
    Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
    Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
    Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
    Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile secretory failure: recent concepts of the pathogenesis of intrahepatic cholestasis.
    Simon FR; Reichen J
    Prog Liver Dis; 1982; 7():195-206. PubMed ID: 7051146
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia.
    Chen HL; Liu YJ; Chen HL; Wu SH; Ni YH; Ho MC; Lai HS; Hsu WM; Hsu HY; Tseng HC; Jeng YM; Chang MH
    Pediatr Res; 2008 Jun; 63(6):667-73. PubMed ID: 18327154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt transporters.
    Meier PJ; Stieger B
    Annu Rev Physiol; 2002; 64():635-61. PubMed ID: 11826283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestasis and the role of basolateral efflux pumps.
    Keppler D
    Z Gastroenterol; 2011 Jul; 49(12):1553-7. PubMed ID: 22139880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile salts and cholestasis.
    Maillette de Buy Wenniger L; Beuers U
    Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
    Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
    Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
    Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
    Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrahepatic cholestasis].
    Adachi Y; Kamisako T
    Nihon Rinsho; 1996 Mar; 54(3):788-93. PubMed ID: 8904238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrahepatic cholestasis in chronic liver disease].
    Roda E; Pezzoli A; Fusaroli P; Fabbri C; Jaboli F; Marchetto S; Azzaroli F; Mazzella G
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():48S-52S. PubMed ID: 9004820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New molecular features of cholestatic diseases of the liver].
    Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
    Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
    Stieger B; Geier A
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.